Logo image of UCL

UCLOUDLINK GROUP INC (UCL) Stock Fundamental Analysis

NASDAQ:UCL - Nasdaq - US90354D1046 - ADR - Currency: USD

1.075  +0.05 (+4.88%)

After market: 1.0414 -0.03 (-3.13%)

Fundamental Rating

4

UCL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 21 industry peers in the Wireless Telecommunication Services industry. UCL has only an average score on both its financial health and profitability. UCL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

UCL had positive earnings in the past year.
UCL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: UCL reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: UCL reported negative operating cash flow in multiple years.
UCL Yearly Net Income VS EBIT VS OCF VS FCFUCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

UCL has a Return On Assets of 7.01%. This is amongst the best in the industry. UCL outperforms 95.24% of its industry peers.
The Return On Equity of UCL (21.08%) is better than 90.48% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.64%, UCL belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
ROA 7.01%
ROE 21.08%
ROIC 11.64%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
UCL Yearly ROA, ROE, ROICUCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

UCL's Profit Margin of 4.97% is fine compared to the rest of the industry. UCL outperforms 61.90% of its industry peers.
UCL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 4.79%, UCL is in line with its industry, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Operating Margin of UCL has declined.
UCL's Gross Margin of 48.41% is on the low side compared to the rest of the industry. UCL is outperformed by 61.90% of its industry peers.
UCL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.79%
PM (TTM) 4.97%
GM 48.41%
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
UCL Yearly Profit, Operating, Gross MarginsUCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

5

2. Health

2.1 Basic Checks

UCL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for UCL has been increased compared to 1 year ago.
UCL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, UCL has a worse debt to assets ratio.
UCL Yearly Shares OutstandingUCL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
UCL Yearly Total Debt VS Total AssetsUCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -2.34, we must say that UCL is in the distress zone and has some risk of bankruptcy.
UCL has a Altman-Z score of -2.34. This is amonst the worse of the industry: UCL underperforms 90.48% of its industry peers.
UCL has a debt to FCF ratio of 1.34. This is a very positive value and a sign of high solvency as it would only need 1.34 years to pay back of all of its debts.
UCL's Debt to FCF ratio of 1.34 is amongst the best of the industry. UCL outperforms 95.24% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that UCL is not too dependend on debt financing.
UCL has a better Debt to Equity ratio (0.32) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.34
Altman-Z -2.34
ROIC/WACC1.44
WACC8.09%
UCL Yearly LT Debt VS Equity VS FCFUCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

UCL has a Current Ratio of 1.32. This is a normal value and indicates that UCL is financially healthy and should not expect problems in meeting its short term obligations.
UCL has a Current ratio of 1.32. This is in the better half of the industry: UCL outperforms 61.90% of its industry peers.
UCL has a Quick Ratio of 1.29. This is a normal value and indicates that UCL is financially healthy and should not expect problems in meeting its short term obligations.
UCL has a Quick ratio of 1.29. This is in the better half of the industry: UCL outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.29
UCL Yearly Current Assets VS Current LiabilitesUCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.00% over the past year.
Measured over the past 5 years, UCL shows a small growth in Earnings Per Share. The EPS has been growing by 3.89% on average per year.
UCL shows a small growth in Revenue. In the last year, the Revenue has grown by 7.07%.
The Revenue for UCL have been decreasing by -10.37% on average. This is quite bad
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%20%
Revenue 1Y (TTM)7.07%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%19.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-150.5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.8%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UCL Yearly Revenue VS EstimatesUCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
UCL Yearly EPS VS EstimatesUCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 -0.5 -1

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.96, the valuation of UCL can be described as very reasonable.
UCL's Price/Earnings ratio is rather cheap when compared to the industry. UCL is cheaper than 80.95% of the companies in the same industry.
UCL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.78.
UCL is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 8.96
Fwd PE N/A
UCL Price Earnings VS Forward Price EarningsUCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

61.90% of the companies in the same industry are more expensive than UCL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.8
EV/EBITDA -1.04
UCL Per share dataUCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.31
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for UCL!.
Industry RankSector Rank
Dividend Yield N/A

UCLOUDLINK GROUP INC

NASDAQ:UCL (4/25/2025, 8:00:01 PM)

After market: 1.0414 -0.03 (-3.13%)

1.075

+0.05 (+4.88%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)03-13 2025-03-13/bmo
Earnings (Next)05-12 2025-05-12
Inst Owners17.72%
Inst Owner Change0%
Ins Owners8.65%
Ins Owner ChangeN/A
Market Cap40.46M
Analysts80
Price Target9.18 (753.95%)
Short Float %0.81%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-297.03%
Min EPS beat(2)-692.08%
Max EPS beat(2)98.02%
EPS beat(4)3
Avg EPS beat(4)-24.75%
Min EPS beat(4)-692.08%
Max EPS beat(4)296.04%
EPS beat(8)5
Avg EPS beat(8)-8.5%
EPS beat(12)6
Avg EPS beat(12)-48.86%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.03%
Min Revenue beat(2)-4.25%
Max Revenue beat(2)2.2%
Revenue beat(4)3
Avg Revenue beat(4)-0.29%
Min Revenue beat(4)-4.25%
Max Revenue beat(4)2.2%
Revenue beat(8)4
Avg Revenue beat(8)-1.47%
Revenue beat(12)6
Avg Revenue beat(12)-1.15%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-120.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-8.9%
Revenue NY rev (3m)-8.9%
Valuation
Industry RankSector Rank
PE 8.96
Fwd PE N/A
P/S 0.44
P/FCF 7.8
P/OCF 4.4
P/B 1.87
P/tB 1.92
EV/EBITDA -1.04
EPS(TTM)0.12
EY11.16%
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.14
FCFY12.82%
OCF(TTM)0.24
OCFY22.71%
SpS2.43
BVpS0.57
TBVpS0.56
PEG (NY)N/A
PEG (5Y)2.31
Profitability
Industry RankSector Rank
ROA 7.01%
ROE 21.08%
ROCE 19.23%
ROIC 11.64%
ROICexc N/A
ROICexgc N/A
OM 4.79%
PM (TTM) 4.97%
GM 48.41%
FCFM 5.66%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
F-Score6
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.34
Debt/EBITDA 1.04
Cap/Depr 171.74%
Cap/Sales 4.36%
Interest Coverage 22.37
Cash Conversion 136.84%
Profit Quality 113.82%
Current Ratio 1.32
Quick Ratio 1.29
Altman-Z -2.34
F-Score6
WACC8.09%
ROIC/WACC1.44
Cap/Depr(3y)133.27%
Cap/Depr(5y)103.42%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%20%
EPS Next Y-150.5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.07%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%19.47%
Revenue Next Year4.8%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.9%
EBIT growth 3YN/A
EBIT growth 5Y-12.3%
EBIT Next Year25.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.79%
FCF growth 3YN/A
FCF growth 5Y12.11%
OCF growth 1Y41.17%
OCF growth 3YN/A
OCF growth 5Y9.78%